EUROSTAT - European Union Statistical Office
EUROSTAT - European Union Statistical Office
04/13/2026 | Press release | Distributed by Public on 04/13/2026 03:04
Medicinal & pharma products: €221 billion trade surplus
In 2025, the EU exported €366.2 billion worth of medicinal and pharmaceutical products and imported €145.7 billion, resulting in a record trade surplus of €220.5 billion.
Compared with 2024, exports rose by 16.0% (from €315.7 billion), and imports increased by 21.0% (from €120.4 billion).
Source dataset: ds-059331
Top extra-EU exporter Ireland, top importer Italy
In 2025, Ireland was the EU's largest exporter of medicinal and pharmaceutical products to countries outside the EU, with exports valued at €93.8 billion, followed by Germany (€67.9 billion) and Belgium (€38.5 billion).
The largest importers from countries outside the EU were Italy (€27.5 billion), Belgium (€24.7 billion) and Germany (€24.2 billion).
Main trade partners: US and Switzerland
The United States was the main destination for extra-EU exports of medicinal and pharmaceutical products in 2025, accounting for 43.8% of all exports, valued at €160.6 billion. Switzerland was the second largest partner (16.3%, €59.7 billion), followed by the United Kingdom (5.6%, €20.6 billion).
Most of the imports to the EU came from the United States (41.2%, €60.1 billion), Switzerland (28.4%, €41.4 billion) and China (9.0%, €13.1 billion).
Source dataset: ds-059331
EUROSTAT - European Union Statistical Office published this content on April 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 13, 2026 at 09:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]